Molecular mechanism of apoptosis induction by resveratrol, a natural cancer chemopreventive agent

International Journal for Vitamin and Nutrition Research

Volumn 78, Issue 1, 2008, Pages 3-8

  Fan, Enguo ^a,c   Jiang, Sha ^a   Zhang, Lijuan ^b   Bai, Yuhua ^a  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Apoptosis; Extrinsic pathway; Intrinsic pathway; Resveratrol

Indexed keywords

CASPASE 9; CERAMIDE; DEATH RECEPTOR; FAS LIGAND; INHIBITOR OF APOPTOSIS PROTEIN; PACLITAXEL; PROTEIN BAK; PROTEIN BAX; RESVERATROL; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN;

APOPTOSIS; ARTICLE; CELL PERMEABILIZATION; CHEMOPROPHYLAXIS; DRUG EFFECT; DRUG MECHANISM; LIGAND BINDING; MEMBRANE DEPOLARIZATION; MITOCHONDRION; NEOPLASM;

ANTICARCINOGENIC AGENTS; APOPTOSIS; BIOLOGICAL PRODUCTS; CHEMOPREVENTION; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; STILBENES;

EID: 48749106316     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831.78.1.3     Document Type: Article

References (48)

1. Fan, E., Zhang, K., Yao, C. et al. (2005) Determination of trans-resveratrol in China Great Wall "Fazenda" red wine by use of micellar electrokinetic chromatography. Chro-matographia 62, 289.
2. Jang, M., Cai, L., Udeani, G.O. et al. (1997) Cancer chemo-preventive activity of resveratrol, a natural product derived from grapes. Science 275, 218.
3. She, Q.B., Bode, A.M., Ma, W.Y. et al. (2001) Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res. 61, 1604.
4. Fulda, S., Jeremias, I. and Debatin, K.M. (2004) Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells. Oncogene 23, 7611.
5. Fan, E., Zhang, L., Jiang, S. et al. (2006) Beneficial effects of resveratrol on atherosclerosis. Natural Product R&D (in submission)
6. Howitz, K.T., Bitterman, K.J., Cohen, H.Y. et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191.
7. Ferreira, C.G., Epping, M., Kruyt, F.A. et al. (2002) Apoptosis: target of cancer therapy. Clin. Cancer Res. 8, 2024.
8. Kasibhatla, S. and Tseng, B. (2003) Why target apoptosis in cancer treatment? Mol. Cancer Ther. 2, 573.
9. Johnstone, R.W., Ruefli, A. A. and Lowe, S.W. (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108, 153.
10. Sellers, W.R. and Fisher, D.E. (1999) Apoptosis and cancer drug targeting. J. Clin. Invest. 104, 1655.
11. Lawen, A. (2003) Apoptosis-an introduction. Bioessays 25, 888.
12. Malaguarnera, L. (2004) Implications of apoptosis regulators in tumorigenesis. Cancer Metastasis Rev. 23, 367.
13. Henry-Mowatt J., Dive, C., Martinou, J.C. et al. (2004) Role of mitochondrial membrane permeabilization in apoptosis and cancer. Oncogene 23, 2850.
14. Bianchini, F. and Vainio, H. (2003) Wine and resveratrol: mechanisms of cancer prevention? Eur. J. Cancer Prev. 12, 417.
15. Oak M.H., EI Bedoui, J. and Schini-Kerth, V.B. (2005) An-tiangiogenic properties of natural polyphenols from red wine and green tea. J. Nutr. Biochem. 16, 1.
16. Clement, M.V., Hirpara, J.L., Chawdhury, S.H. et al. (1998) Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92, 996.
17. Bernhard, D., Tinhofer, I., Tonko, M. et al. (2000) Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ. 7, 834.
18. Tsan, M.F., White, J.E., Maheshwari, J.G. et al. (2000) Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells. Br. J. Haematol. 109, 405.
19. Dorrie, J., Gerauer, H., Wachter, Y. et al. (2001) Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res. 61, 4731.
20. Su, J.L., Lin, M.T., Hong, C.C. et al. (2005) Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASKl/JNK-dependent signaling pathway in human leukemia HL-60 cells. Carcinogenesis 26, 1.
21. Fulda, S. and Debatin, K.M. (2004) Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res. 64, 337.
22. Delmas, D., Rebe, C., Lacour, S. et al. (2003) Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J. Biol. Chem. 278, 41482.
23. Wang, Y., Wang, B., Cheng, J. et al. (2005) FADD-depen-dent apoptosis induction in Jurkat leukemia T-cells by the resveratrol analogue, 3,4,5-trihydroxy-trans-stilbene. Biochem. Pharmacol. 69, 249.
24. Delmas, D., Rebe, C., Micheau, O. et al. (2004) Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene 23, 8979.
25. Fulda, S. and Debatin, K.M. (2005) Resveratrol-mediated sensitisation to TRAIL-induced apoptosis depends on death receptor and mitochondrial signaling. Eur. J. Cancer 41, 786.
26. Jiang, H., Zhang, L., Kuo, J. et al. (2005) Resveratrol-in-duced apoptotic death in human U251 glioma cells. Mol. Cancer Ther. 4, 554.
27. Jazirehi, A.R. and Bonavida, B. (2004) Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol. Cancer Ther. 3, 71.
28. Gautam, S.C.,Groc, L., Rodriguez, A.I. et al. (2005) Resveratrol-induced apoptotic death in human U251 glioma cells. Mol. Cancer Ther. 4, 554.
29. Wang, F., Liu, H.Y., Fu, Z.D. et al. (2005) Resveratrol induces apoptosis and differentiation in acute promyelocytic leukemia (NB4) cells. J. Asian Nat. Prod. Res. 7, 633.
30. Ohguchi, K., Akao,Y., Matsumoto, K. et al. (2005) Vaticanol C-induced cell death is associated with inhibition of pro-survival signaling in HL60 human leukemia cell line. Biosci. Biotechnol. Biochem. 69, 353.
31. Das, S., Cordis, G.A., Maulik, N. et al. (2005) Pharmacological preconditioning with resveratrol: role of CREB-de-pendent Bcl-2 signaling via adenosine A3 receptor activation. Am. J. Physiol. Heart Circ. Physiol. 288, H328.
32. Kim, Y.A., Choi, B.T., Lee, Y.T. et al. (2004) Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells. Oncol. Rep. 11, 441.
33. Shimizu, T., Nakazato, T., Xian, M.J. et al. (2006) Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways. Biochem. Pharmacol. 71, 742.
34. Zunino, S.J. and Storms, D.H. (2006) Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore. Cancer Lett. 240, 123.
35. Lee, E.O., Kwon, B.M., Song, G.Y. et al. (2004) Heyneanol A induces apoptosis via cytochrome c release and caspase activation in human leukemic U937 cells [J]. Life Sci. 74, 2313.
36. Kim, YA., Rhee, S.H., Park, K.Y et al. (2003) Antiproliferative effect of resveratrol in human prostate carcinoma cells. J. Med. Food 6, 273.
37. Scarlatti, E., Sala, G., Somenzi, G. et al. (2003) Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J. 17, 2339.
38. Minutolo, F., Sala, G., Bagnacani, A. et al. (2005) Synthesis of a Resveratrol Analogue with High Ceramide-Mediat-ed Proapoptotic Activity on Human Breast Cancer Cells. J. Med. Chem. 48, 6783.
39. Sala, G., Minutolo, F., Macchia, M. et al. (2003) Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells. Drugs Exp. Clin. Res. 29, 263.
40. Hayashibara, T., Yamada, Y., Nakayama, S. et al. (2002) Resveratrol induces downregulation in survivin expression and apoptosis in HTLV-1-infected cell lines: a prospective agent for adult T cell leukemia chemotherapy. Nutr. Cancer 44, 193.
41. Fulda, S. and Debatin, K.M. (2004) Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. Oncogene 23, 6702.
42. Aziz, M.H., Afaq, E and Ahmad, N. (2005) Prevention of ultraviolet-B radiation damage by resveratrol in mouse skin is mediated via modulation in surviving. Photochem. Pho-tobiol. 81,25.
43. Burns, J., Yokota, T., Ashihara, H. et al. (2002) Plant foods and herbal sources of resveratrol. J. Agric. Food Chem. 50, 3337.
44. Sun, A.Y., Simonyi, A. and Sun, G.Y (2002) The "French Paradox" and beyond: neuroprotective effects of polyphenols. Free Radic. Biol. Med. 32, 314.
45. Dorai, T. and Aggarwal, B.B. (2004) Role of chemopreventive agents in cancer therapy. Cancer Lett. 215, 129.
46. Kundu, J.K. and Surh, Y.J. (2004) Molecular basis of chemo-prevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat. Res. 555, 65.
47. Aziz, M.H., Kumar, R. and Ahmad, N. (2003) Cancer chemo-prevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms. Int. J. Oncol. 23, 17.
48. Baur, J.A. and Sinclair, D.A. (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5, 493.